MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
54 hedge funds and large institutions have $37.9M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Holders
54
Holding in Top 10
1
Calls
$110K
Puts
$49K
Top Buyers
| 1 | +$2.38M | |
| 2 | +$1.91M | |
| 3 | +$1.78M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$578K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$404K |
Top Sellers
| 1 | -$2.79M | |
| 2 | -$1.59M | |
| 3 | -$1.22M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$587K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$276K |